Birdwatch Note Rating
2023-03-16 01:44:49 UTC - NOT_HELPFUL
Rated by Participant: 17E746A1FC5185292CC1AAB4350F7A3EFFE915E2A3144A395A8EEE968E57FCBA
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details